Adaptive Biotechnologies Corporation (ADPT) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$14.21
Day's range
$15.17

Adaptive Biotechnologies Corp Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VIKING GLOBAL INVESTORS LP 08/14/2026 29.99 M $643.37 M   0.00% 19.29%
BLACKROCK, INC. 08/07/2026 15.14 M $324.73 M   13.80% 9.73%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 6.40 M $137.36 M   5.08% 4.12%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 5.91 M $126.80 M   53.25% 3.80%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 5.48 M $117.47 M   21.93% 3.52%
D. E. SHAW & CO., INC. 08/14/2026 4.63 M $99.22 M   135.34% 2.97%
WESTFIELD CAPITAL MANAGEMENT CO LP 08/12/2026 4.27 M $91.54 M   -21.50% 2.74%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 3.64 M $78.13 M   0.16% 2.34%
STATE STREET CORP 08/07/2026 3.46 M $74.18 M   7.16% 2.22%
INVESCO LTD. 08/14/2026 3.09 M $66.37 M   -30.47% 1.99%
GOLDMAN SACHS GROUP INC 08/14/2026 2.98 M $64.01 M   -7.95% 1.92%
UBS GROUP AG 08/13/2026 2.86 M $61.39 M   100.00% 1.84%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 2.67 M $57.17 M   70.18% 1.71%
DRIEHAUS CAPITAL MANAGEMENT LLC 08/14/2026 2.53 M $54.22 M   44.39% 1.63%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 08/13/2026 2.52 M $54.15 M   26.53% 1.62%
LORD, ABBETT & CO. LLC 08/14/2026 2.47 M $53.09 M   -30.01% 1.59%
NUVEEN, LLC 08/11/2026 2.37 M $50.75 M   81.43% 1.52%
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 08/13/2026 2.18 M $46.81 M   -18.81% 1.40%
FRED ALGER MANAGEMENT, LLC 08/14/2026 2.09 M $44.88 M   1.41% 1.35%
ARK INVESTMENT MANAGEMENT LLC 08/14/2026 2.09 M $44.84 M   -0.13% 1.34%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 1.97 M $42.28 M   5,873.64% 1.27%
MACQUARIE MANAGEMENT HOLDINGS, INC. 08/14/2026 1.89 M $40.52 M   0.43% 1.21%
ARISTOTLE ATLANTIC PARTNERS, LLC 08/14/2026 1.84 M $39.44 M   7.24% 1.18%
TORONTO DOMINION BANK 08/14/2026 1.80 M $38.61 M   100.00% 1.16%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 08/14/2026 1.78 M $38.17 M   93.59% 1.14%
BANK OF AMERICA CORP /DE/ 08/14/2026 1.73 M $37.11 M   40.89% 1.11%
JANE STREET GROUP, LLC 08/14/2026 1.59 M $34.12 M   133.15% 1.02%
NORTHERN TRUST CORP 08/13/2026 1.51 M $32.33 M   8.26% 0.97%
SUMITOMO MITSUI TRUST GROUP, INC. 07/30/2026 1.33 M $28.53 M   -16.64% 0.86%
NIKKO ASSET MANAGEMENT AMERICAS, INC. 08/13/2026 1.33 M $28.51 M   -16.64% 0.86%
OBERWEIS ASSET MANAGEMENT INC/ 08/14/2026 1.26 M $27.00 M   55.99% 0.81%
PERCEPTIVE ADVISORS LLC 08/14/2026 1.22 M $26.11 M   698.25% 0.78%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 1.18 M $25.28 M   2.87% 0.76%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 1.18 M $25.28 M   100.00% 0.76%
AMERIPRISE FINANCIAL INC 08/14/2026 1.09 M $23.33 M   -63.95% 0.70%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 08/03/2026 1.07 M $22.99 M   -0.04% 0.69%
BLUE WATER LIFE SCIENCE ADVISORS, LP 08/14/2026 1.01 M $21.67 M   0.00% 0.65%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 934.71 K $20.05 M   7.32% 0.60%
ABRDN PLC 07/31/2026 919.00 K $19.71 M   -14.16% 0.59%
FREESTONE GROVE PARTNERS LP 08/14/2026 881.69 K $18.91 M   100.00% 0.57%
KENNEDY CAPITAL MANAGEMENT LLC 08/14/2026 849.80 K $18.23 M   -8.77% 0.55%
HRT FINANCIAL LP 08/14/2026 795.17 K $17.06 M   505.88% 0.51%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 08/13/2026 785.90 K $16.86 M   20.98% 0.51%
PANAGORA ASSET MANAGEMENT INC 08/06/2026 777.62 K $16.68 M   50.72% 0.50%
MORGAN STANLEY 08/13/2026 766.23 K $16.44 M   -20.77% 0.49%
GRANITE INVESTMENT PARTNERS, LLC 08/07/2026 757.22 K $16.24 M   51.42% 0.49%
TREXQUANT INVESTMENT LP 08/14/2026 736.26 K $15.79 M   28.81% 0.47%
FMR LLC 08/13/2026 709.53 K $15.22 M   25.13% 0.46%
JENNISON ASSOCIATES LLC 08/03/2026 686.20 K $14.72 M   -8.88% 0.44%
HILLSDALE INVESTMENT MANAGEMENT INC. 08/12/2026 684.22 K $14.68 M   9.44% 0.44%

Adaptive Biotechnologies Corp institutional Ownership - FAQ's

During the previous two years, 405 institutional investors and hedge funds held shares of Adaptive Biotechnologies Corp. The most heavily invested institutionals were:

VIKING GLOBAL INVESTORS LP: 29.99 M

BlackRock, Inc.: 15.14 M

VANGUARD CAPITAL MANAGEMENT LLC: 6.4 M

WELLINGTON MANAGEMENT GROUP LLP: 5.91 M

VANGUARD PORTFOLIO MANAGEMENT LLC: 5.48 M

D. E. Shaw & Co., Inc.: 4.63 M

100.79% of Adaptive Biotechnologies Corp stock is owned by institutional investors.

Institutional investors have bought a total of 186.03 M shares in the last 24 months. This purchase volume represents approximately $2.78 B in transactions.